Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (13)

1

Dose-adjusted EPOCH and rituximab for the treatment of double expressor and double-hit diffuse large B-cell lymphoma : impact of TP53 mutations on clinical outcome

enthalten in: Haematologica | 2022

von Dodero, A. | Guidetti, A. | Marino, F. | +20

2

Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases

enthalten in: Transplantation and cellular therapy | 2021

von Sarina, B. | Mancosu, P. | Navarria, P. | +11

3

Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas

enthalten in: Transplantation and cellular therapy | 2021

von Castagna, L. | Dodero, A. | Patriarca, F. | +13

4

Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2020

von Montes de Oca, C. | Castagna, L. | De Philippis, C. | +15

5

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide

enthalten in: Cancer medicine | 2020

von Mariotti, J. | Taurino, D. | Marino, F. | +10

6

Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2019

von Mariotti, J. | Devillier, R. | Bramanti, S. | +16

7

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

enthalten in: Bone marrow transplantation | 2019

von Mariotti, J. | Granata, A. | Bramanti, S. | +12

8

Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide

enthalten in: European journal of haematology | 2019

von Mariotti, J. | De Philippis, C. | Bramanti, S. | +7

9

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation : Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2018

von Mariotti, J. | Devillier, R. | Bramanti, S. | +12

10

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2014

von Castagna, L. | Crocchiolo, R. | Furst, S. | +12